1. Labrie F, Dupont A, Cusan L et al. Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lu-pron: the first controlled and randomized trial. Clin Invest Med 1993; 16(6): 499–509.
2. Brawer MK, Chetner MP, Beatie J et al. Screening for prostatic carcinoma with prostate specific antigen. J Urol 1992; 147(3 Pt 2): 841–5.
3. Han M, Partin AW, Pound CR et al. Long-term biochemical disease-free and cancer-specific survival following anatomic rad-ical retropubic prostatectomy. The 15-year Johns Hopkins expe-rience. Urol Clin North Am 2001; 28(3): 555–65.
4. Rees MA, Resnick MI, Oesterling JE. Use of prostate-specific antigen, Gleason score, and digital rectal examination in staging patients with newly diagnosed prostate cancer. Urol Clin North Am 1997; 24(2): 379–88.
5. Olsson CA, de Vries GM, Buttyan R, Katz AE. Reverse transcriptase-polymerase chain reaction assays for prostate can-cer. Urol Clin North Am 1997; 24(2): 367–78.